Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel Nicotine Replacement Therapy for Smoking Cessation
NCT01296698Phase 3Terminated
- Sponsor
- McNeil Laboratories
- Start
- Mar 2011
- Primary completion
- Apr 2011
- Countries
- 1
01
Overview
A Phase 3 trial of nicotine in tobacco dependence, sponsored by McNeil Laboratories. Started Mar 2011; status: terminated.
02
Drugs
nicotine
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT01296698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01296698.